Exhibition Preview: Distolife will be exhibiting at the 12th South China Structural Biology Conference (SCSBC 2026), where we will jointly explore new frontiers in membrane protein research and development.

I. Conference Overview: China's premier academic gathering in structural biology

The 12th South China Structural Biology Conference (SCSBC 2026), jointly organized by the Chinese Biophysical Society and the Chinese Crystallographic Society, will be grandly held from October 23 to 25,2026, in Changsha, Hunan Province. The conference is chaired by Academician Rao Zihe and brings together nearly a thousand experts, young scholars, and industry R&D professionals from universities, research institutes, and biomedical enterprises across China. It stands as a benchmark event in the field of structural biology in South China and throughout China, characterized by its large scale, high academic standards, and deep integration of industry, academia, and research.

This conference focuses on cutting-edge topics such as protein structure and function, novel cryo-electron microscopy and X-ray crystallography techniques, membrane protein target research, protein design, and structure-driven drug discovery. It features a diverse program encompassing keynote lectures, sub-forum sessions, dedicated sessions for young scholars, corporate booths, and poster presentations, thereby establishing a high-level platform for interdisciplinary collaboration between academia and industry. The conference aims to address key challenges in the study of complex membrane proteins—including GPCRs, ion channels, and transporters—and to facilitate the translation of innovative drug targets into clinical applications.

II. Distolife has been invited to exhibit, demonstrating its commitment to advancing full-spectrum R&D for membrane proteins and empowering related fields.

Distolife, an innovative high-tech enterprise specializing in the field of membrane proteins in China, will showcase its complete suite of membrane protein research tools and integrated CRO service solutions at this conference, presenting domestic high-end membrane protein solutions to structural biology researchers and R&D teams from pharmaceutical companies across the country; we sincerely invite all experts and colleagues to visit our booth for networking and discussions.

Distolife adheres to a dual-drive development strategy centered on "high-purity tools for membrane protein research + integrated CRO services," guided by its core philosophy of "Deep expertise in membrane proteins, ultimate specialization." The core team comprises seasoned experts in structural biology, organic synthesis, and quality control; aligning with world-class quality standards, Distolife seamlessly integrates the entire R&D pipeline—from protein sample preparation to drug mechanism elucidation.

This exhibition focuses on showcasing two major business segments.

(1) High-end Membrane Protein Research Reagent Series

Our featured new product is LMNG—characterized by a purity ≥99%, ultra-low CMC, gentle protection of GPCRs and ion channels, and preservation of their native conformations, making it ideal for high-resolution structural determination experiments such as cryo-electron microscopy and protein crystallization; alongside this, we are also showcasing our full range of MNG-and NG-based nonionic detergents—including DDM, OG, LMNG, and DM—available in multiple specifications as ready-to-use stock, with custom large-packaging options available.

(2) Integrated Membrane Protein CRO Technology Service Platform

Leveraging its two core technologies—cryo-electron microscopy and X-ray crystallography—Distolife offers a one-stop outsourced service covering the entire R&D lifecycle, providing customized solutions specifically tailored for challenging membrane protein targets:

1. High-difficulty membrane protein expression, extraction, stabilization, and purification;

2. Cryo-EM and X-ray crystallography-based three-dimensional structure determination of GPCR/ion channel/transporter targets;

3. Structure-Based Drug Design (SBDD);

4. Structure–Activity Relationship (SAR) analysis and validation of the mechanism of action;

5. Bio-molecular interaction analysis (SPR/BLI/Thermodynamic displacement screening).

We can provide research institutes and innovative pharmaceutical companies with end-to-end closed-loop services spanning the entire pipeline—from "protein → three-dimensional structure → candidate drug → mechanism of action" —and possess unique technical advantages in areas such as non-ionic detergent-free membrane protein stabilization systems, flexible membrane protein structure determination, and lead compound optimization, striving to overcome the key bottlenecks in the translational research and development of membrane proteins into therapeutics.

III. Highlights of the Conference Discussions

1. New Product Technology Live Demonstration

2. The presentation showcased application cases of the LMNG series products, shared a standardized protocol for preparing detergent-free membrane protein samples, and compared the performance advantages of traditional detergents in cryo-electron microscopy imaging and protein activity preservation.

2. One-on-one technical solution consultation

3. Our senior structural biology and reagent R&D engineers provide on-site support to address existing laboratory challenges—such as difficulties in membrane protein extraction, poor in vitro stability, high EM background, low crystallization success rates, and false-negative results in drug-binding experiments—by offering customized optimization solutions.

3. Industry-University-Research Collaboration Negotiations

4. We offer open access to reagent co-development partnerships and joint research projects for university research groups; we also provide long-term CRO turnkey services and customized bulk reagent solutions with exclusive preferential pricing for biopharmaceutical enterprises.

4. Industry Frontiers Exchange

5. We will engage in in-depth discussions with leading membrane protein research teams and cryo-electron microscopy platform experts to explore recent advancements in detergent-free membrane simulation, high-resolution structural determination, and the development of novel membrane protein-based therapeutics.

IV. Corporate Mission and Vision

Distolife has always embraced its mission of "Empowering life sciences exploration and accelerating innovative drug discovery," focusing on clinically prominent yet challenging membrane protein targets—such as GPCRs, ion channels, and transporters—to continuously fill the gap in China's market for high-end membrane protein reagents and one-stop structural biology CRO services, thereby developing cost-effective domestic alternatives.

At this SCSBC 2026 event, Distolife looks forward to collaborating with peers across China to break down barriers in industry-academia-research translation, and jointly drive the iterative advancement of structural biology technologies and the high-quality development of the membrane protein-based innovative drug R&D sector.

V. Conference Information Preview

• Conference Name: The 12th South China Structural Biology Conference (SCSBC 2026)

• Event Dates: October 23–25,2026

• Venue: Changsha, Hunan

• Distolife Booth Number: This will be updated on the official website in due course; please stay tuned.

• Advance Appointment Consultation: If you would like to schedule a one-on-one consultation with a technical expert prior to the event, you may submit your request through the "Contact Us" section on our official website.